lipoxin-b4 and Peritonitis

lipoxin-b4 has been researched along with Peritonitis* in 2 studies

Other Studies

2 other study(ies) available for lipoxin-b4 and Peritonitis

ArticleYear
A cluster of immunoresolvents links coagulation to innate host defense in human blood.
    Science signaling, 2017, Aug-01, Volume: 10, Issue:490

    Blood coagulation is a protective response that prevents excessive bleeding upon blood vessel injury. We investigated the relationship between coagulation and the resolution of inflammation and infection by lipid mediators (LMs) through metabololipidomics-based profiling of human whole blood (WB) during coagulation. We identified temporal clusters of endogenously produced prothrombotic and proinflammatory LMs (eicosanoids), as well as specialized proresolving mediators (SPMs). In addition to eicosanoids, a specific SPM cluster was identified that consisted of resolvin E1 (RvE1), RvD1, RvD5, lipoxin B

    Topics: Animals; Blood Coagulation; Cells, Cultured; Docosahexaenoic Acids; Escherichia coli; Hemorrhagic Disorders; Humans; Immunity, Innate; Leukocytes; Lipoxins; Macrophages; Male; Mice; Neutrophils; Peritonitis; Phagocytosis

2017
Aromatic lipoxin A4 and lipoxin B4 analogues display potent biological activities.
    Journal of medicinal chemistry, 2007, Nov-29, Volume: 50, Issue:24

    Lipoxins are a group of biologically active eicosanoids typically formed by transcellular lipoxygenase activity. Lipoxin A4 (LXA4) and Lipoxin B4 (LXB4) biosynthesis has been detected in a variety of inflammatory conditions. The native lipoxins LXA4 and LXB4 demonstrate potent antiinflammatory and proresolution bioactions. However, their therapeutic potential is compromised by rapid metabolic inactivation by PG dehydrogenase-mediated oxidation and reduction. Here we report on the stereoselective synthesis of aromatic LXA4 and LXB4 analogues by employing Sharpless epoxidation, Pd-mediated Heck coupling, and diastereoselective reduction as the key transformations. Subsequent biological testing has shown that these analogues display potent biological activities. Phagocytic clearance of apoptotic leukocytes plays a critical role in the resolution of inflammation. Both LXA4 analogues (1R)-3a and (1S)-3a were found to stimulate a significant increase in phagocytosis of apoptotic polymorphonuclear leukocytes (PMN) by macrophages, with comparable efficacy to the effect of native LXA4, albeit greater potency, while the LXB4 analogue also stimulated phagocytosis with a maximum effect observed at 10-11 M. LX-stimulated phagocytosis was associated with rearrangement of the actin cytoskeleton consistent with that reported for native lipoxins. Using zymosan-induced peritonitis as a murine model of acute inflammation (1R)-3a significantly reduced PMN accumulation.

    Topics: Actins; Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Cell Adhesion; Cell Differentiation; Cell Line, Tumor; Humans; Laminin; Lipoxins; Mice; Neutrophils; Peritonitis; Phagocytosis; Stereoisomerism; Structure-Activity Relationship

2007